Om

Aptose Biosciences Inc. is a clinical-stage biotechnology company focused on developing precision medicines to address unmet medical needs in oncology, primarily targeting hematological cancers. The company's pipeline features small molecule therapeutics designed both for single-agent efficacy and for enhancing the effectiveness of existing anti-cancer treatments without overlapping toxicities. Aptose aims to create personalized cancer therapies that improve patient outcomes by targeting specific molecular pathways. Operating within the pharmaceutical and biotech industry, Aptose plays an active role in advancing innovative cancer treatments through clinical trials and strategic collaborations, contributing to the evolving landscape of precision oncology.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I APTOSE BIOSCIENCES MED ENDAVU: Køb Aptose Biosciences ($LTI0) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Aptose Biosciences, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.